Quarterly report pursuant to Section 13 or 15(d)

NATURE OF BUSINESS AND ORGANIZATION (Details)

v3.24.1.1.u2
NATURE OF BUSINESS AND ORGANIZATION (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Sep. 30, 2022
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Accumulated deficit   $ 239,064,176   $ 217,482,539
Net Income (Loss)   (21,581,637) $ (8,581,267)  
Long-lived fixed asset impairment charges   0    
Uninsured cash balances   39,587,000   9,123,000
Cancer treatment research award through the National Cancer Institute (NCI)        
Government Assistance Amount Cumulative   $ 2,000,000.0    
Government Assistance Transaction Duration   3 years    
Grant received $ 1,980,000 $ 324,000   $ 1,759,000
Leasehold improvements        
Property and equipment useful lives   64 months    
Minimum        
Property and equipment useful lives   3 years    
Share-based compensation expiration period   12 months    
Maximum        
Property and equipment useful lives   10 years    
Share-based compensation expiration period   3 years